Identification of novel inhibitors of UDP-Glc 4′-epimerase, a validated drug target for african sleeping sickness

Identification of novel inhibitors of UDP-Glc 4′-epimerase, a validated drug target for african sleeping sickness Computer-Aided Identification ofTrypanosoma bruceiUridine Diphosphate Galactose 4′-Epimerase Inhibitors: Toward the Development of Novel Therapies for African Sleeping Sickness Pharmacological Validation of Trypanosoma brucei Phosphodiesterases B1 and B2 as Druggable Targets for African Sleeping Sickness Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis Identification of ML251, a Potent Inhibitor ofT. brucei and T. cruziPhosphofructokinase 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness